Back to search

Article

A spectrum of <i>BRCA1</i> and <i>BRCA2</i> germline deleterious variants in ovarian cancer in Russia

2021-07-25

Abstract excerpt

Pathogenic mutations in BRCA1 and BRCA2 genes are essential biomarkers of an increased breast and ovarian cancer risk and tumor sensitivity to poly ADP ribose (PARP) inhibitors. In many countries, their detection includes patient prescreening with quantitative PCR (qPCR) identifying several founder mutations. In Russia, eight mutations are included in such tests, among which c.5266dup (5382insC) is the most freque...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5ddac8b6-60c8-59ce-9dde-de78493febc8
DOI
10.1101/2021.07.22.21260831
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A spectrum of <i>BRCA1</i> and <i>BRCA2</i> germline deleterious variants in ovarian cancer in RussiaDOI 10.1101/2021.07.22.21260831
Select a neighboring publication to make it the new centre.